_id
6910503accc777a4e85d53ee
Ticker
CLTEF
Name
Calliditas Therapeutics AB (publ)
Exchange
PINK
Address
Kungsbron 1, D5, Stockholm, Sweden, 111 22
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.calliditas.se
Description
Calliditas Therapeutics AB (publ), a commercial-stage specialty pharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was founded in 2004 and is headquartered in Stockholm, Sweden.
Last Close
0.7
Volume
2000
Current Price
0.5477
Change
-57.14285714285714
Last Updated
2026-01-02T11:33:15.073Z
Image
data:image/webp;base64,UklGRm4BAABXRUJQVlA4IGIBAADwCgCdASpAAEAAPrVKoEwnI6MiLhSaqOAWiWoA0QXAvr/rl7GcT/IG9Z8wHnt+gDzmeor9ADpTX1HWlvzcZPvx7WuUHxNScP4InSTLrrEVLYd3+17iAzG8M2jtoIy5mEAA/vEpL/nYPx770eOf1dOUYvDp4S7RMYschssx2LCF3yVIh/0A9cDjTXMRccxC7CtZ9ZjFe1XT1iU98rSgonUvyLmod//b2RTxj8bhkfBTejYgH+fj0pbtdTZzx4VZnq6Xz3hc4kJJRhoJIHGSShYVp0+/8ShHzbg2jued0m/yqj3L1ZsnPcw/sCLlg5mZdOJ6+ciWbJlqyVQm2/aWQA83iTD0lvED0PYeOkFCosCbq0iSuR9EfLD8opLtxR+VlllgoYTd36rNckN/9RLIfG01X3lkLOXSSpU35usgfSCzBhVXZxJhwy3Cq5hIsS7Gs/OEL/7VmvxQDt+WogQmismVgAA=
Ipo Date
-
Market Cap
504719776
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
49.47
Cost Of Revenue
7093
Gross Profit
-7043
Operating Expenses
123811
Operating Income
-130855
Interest Expense
256.81
Pretax Income
-135365
Net Income
-135365
Eps
-0.00552185969495626
Dividends Per Share
-
Shares Outstanding
53672100
Income Tax Expense
-
EBITDA
-128018
Operating Margin
-264513.84677582374
Total Other Income Expense Net
-4509
Cash
562535
Short Term Investments
-
Receivables
2699
Inventories
-
Total Current Assets
575921
Property Plant Equipment
-
Total Assets
3273509
Payables
4582
Short Term Debt
-
Long Term Debt
-
Total Liabilities
5236
Equity
3268272
Bs_currency_symbol
-
Depreciation
7093
Change In Working Capital
-77397
Cash From Operations
-205662
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
745203
Net Change In Cash
539548
Cf_currency_symbol
-
PE
-
PB
4.108143144817812
ROE
-4.14179113611107
ROA
-4.135165047659866
FCF
-205662
Fcf Percent
-4157.307459066101
Piotroski FScore
0
Health Score
29
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
49.47
Quarters > 0 > income Statement > cost Of Revenue
7093
Quarters > 0 > income Statement > gross Profit
-7043
Quarters > 0 > income Statement > operating Expenses
123811
Quarters > 0 > income Statement > operating Income
-130855
Quarters > 0 > income Statement > interest Expense
256.81
Quarters > 0 > income Statement > pretax Income
-135365
Quarters > 0 > income Statement > net Income
-135365
Quarters > 0 > income Statement > eps
-0.00552185969495626
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
24514386
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-128018
Quarters > 0 > income Statement > operating Margin
-264513.84677582374
Quarters > 0 > income Statement > total Other Income Expense Net
-4509
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
562535
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2699
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
575921
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
3273509
Quarters > 0 > balance Sheet > payables
4582
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5236
Quarters > 0 > balance Sheet > equity
3268272
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-135365
Quarters > 0 > cash Flow > depreciation
7093
Quarters > 0 > cash Flow > change In Working Capital
-77397
Quarters > 0 > cash Flow > cash From Operations
-205662
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
745203
Quarters > 0 > cash Flow > net Change In Cash
539548
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00552185969495626
Quarters > 0 > ratios > PB
4.108143144817812
Quarters > 0 > ratios > ROE
-4.14179113611107
Quarters > 0 > ratios > ROA
-4.135165047659866
Quarters > 0 > ratios > FCF
-205662
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-4157.307459066101
Quarters > 0 > health Score
29
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
7091
Quarters > 1 > income Statement > gross Profit
-7091
Quarters > 1 > income Statement > operating Expenses
79651
Quarters > 1 > income Statement > operating Income
-86742
Quarters > 1 > income Statement > interest Expense
205.83
Quarters > 1 > income Statement > pretax Income
18388
Quarters > 1 > income Statement > net Income
18388
Quarters > 1 > income Statement > eps
0.000834551181388256
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
22033400
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
25683
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
105131
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
22987
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
22987
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
2726924
Quarters > 1 > balance Sheet > payables
68574
Quarters > 1 > balance Sheet > short Term Debt
43638
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
112858
Quarters > 1 > balance Sheet > equity
2614065
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
18388
Quarters > 1 > cash Flow > depreciation
7091
Quarters > 1 > cash Flow > change In Working Capital
-30254
Quarters > 1 > cash Flow > cash From Operations
-105632
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
126614
Quarters > 1 > cash Flow > net Change In Cash
21051
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.000834551181388256
Quarters > 1 > ratios > PB
4.61644724978147
Quarters > 1 > ratios > ROE
0.7034255077819411
Quarters > 1 > ratios > ROA
0.674312888808049
Quarters > 1 > ratios > FCF
-105632
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
569686
Quarters > 2 > income Statement > gross Profit
-6735
Quarters > 2 > income Statement > operating Expenses
81992
Quarters > 2 > income Statement > operating Income
-651678
Quarters > 2 > income Statement > interest Expense
127.81
Quarters > 2 > income Statement > pretax Income
-715390
Quarters > 2 > income Statement > net Income
-66427
Quarters > 2 > income Statement > eps
-0.0043136788107761516
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15399153
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-651678
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-63711
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
20840446
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
272049000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
27196
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
834122
Quarters > 2 > balance Sheet > payables
90938
Quarters > 2 > balance Sheet > short Term Debt
1055042647
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
188903
Quarters > 2 > balance Sheet > equity
645218
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-715390
Quarters > 2 > cash Flow > depreciation
72543
Quarters > 2 > cash Flow > change In Working Capital
179067
Quarters > 2 > cash Flow > cash From Operations
-33846
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-35977
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0043136788107761516
Quarters > 2 > ratios > PB
13.071730946904767
Quarters > 2 > ratios > ROE
-10.295280044884054
Quarters > 2 > ratios > ROA
-7.963703151337574
Quarters > 2 > ratios > FCF
-33846
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
559780000
Quarters > 3 > income Statement > cost Of Revenue
53448000
Quarters > 3 > income Statement > gross Profit
506332000
Quarters > 3 > income Statement > operating Expenses
537835000
Quarters > 3 > income Statement > operating Income
-31503000
Quarters > 3 > income Statement > interest Expense
11158000
Quarters > 3 > income Statement > pretax Income
-42661000
Quarters > 3 > income Statement > net Income
-47478000
Quarters > 3 > income Statement > eps
-0.8843490227829677
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
53686948
Quarters > 3 > income Statement > income Tax Expense
4817000
Quarters > 3 > income Statement > EBITDA
-30444500
Quarters > 3 > income Statement > operating Margin
-5.627746614741506
Quarters > 3 > income Statement > total Other Income Expense Net
-11158000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
797278000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
222586000
Quarters > 3 > balance Sheet > inventories
40164000
Quarters > 3 > balance Sheet > total Current Assets
1154464000
Quarters > 3 > balance Sheet > property Plant Equipment
59356000
Quarters > 3 > balance Sheet > total Assets
1747205000
Quarters > 3 > balance Sheet > payables
151015000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1640416000
Quarters > 3 > balance Sheet > equity
106789000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-47478000
Quarters > 3 > cash Flow > depreciation
1058500
Quarters > 3 > cash Flow > change In Working Capital
-32406000
Quarters > 3 > cash Flow > cash From Operations
-7043000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-102000
Quarters > 3 > cash Flow > cash From Financing
-4046000
Quarters > 3 > cash Flow > net Change In Cash
-13039000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.8843490227829677
Quarters > 3 > ratios > PB
0.27534990888200095
Quarters > 3 > ratios > ROE
-44.45963535570143
Quarters > 3 > ratios > ROA
-2.717368597273932
Quarters > 3 > ratios > FCF
-7043000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.012581728536210654
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
18209
Annuals > 0 > income Statement > cost Of Revenue
28364
Annuals > 0 > income Statement > gross Profit
-10155
Annuals > 0 > income Statement > operating Expenses
1892959000
Annuals > 0 > income Statement > operating Income
-207290
Annuals > 0 > income Statement > interest Expense
755.66
Annuals > 0 > income Statement > pretax Income
-101711
Annuals > 0 > income Statement > net Income
-101711
Annuals > 0 > income Statement > eps
-0.0000059882199665696825
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
16985181000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1718106000
Annuals > 0 > income Statement > operating Margin
-1138.3931023120435
Annuals > 0 > income Statement > total Other Income Expense Net
105579
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
22987
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
22987
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
2726924
Annuals > 0 > balance Sheet > payables
68574
Annuals > 0 > balance Sheet > short Term Debt
43638
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
112858
Annuals > 0 > balance Sheet > equity
2614065
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-976666000
Annuals > 0 > cash Flow > depreciation
272367000
Annuals > 0 > cash Flow > change In Working Capital
60730
Annuals > 0 > cash Flow > cash From Operations
-114471
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
126614
Annuals > 0 > cash Flow > net Change In Cash
12052
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.0000059882199665696825
Annuals > 0 > ratios > PB
1819.3314550326793
Annuals > 0 > ratios > ROE
-3.890913194583914
Annuals > 0 > ratios > ROA
-3.7298802606893333
Annuals > 0 > ratios > FCF
-114471
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-6.286506672524576
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1206888000
Annuals > 1 > income Statement > cost Of Revenue
60463000
Annuals > 1 > income Statement > gross Profit
1146425000
Annuals > 1 > income Statement > operating Expenses
1519480000
Annuals > 1 > income Statement > operating Income
-373055000
Annuals > 1 > income Statement > interest Expense
44104000
Annuals > 1 > income Statement > pretax Income
-457017000
Annuals > 1 > income Statement > net Income
-466185000
Annuals > 1 > income Statement > eps
-8.685802665814876
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
53672069
Annuals > 1 > income Statement > income Tax Expense
9168000
Annuals > 1 > income Statement > EBITDA
-386350000
Annuals > 1 > income Statement > operating Margin
-30.910490451475198
Annuals > 1 > income Statement > total Other Income Expense Net
-83962000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
973733000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
180892000
Annuals > 1 > balance Sheet > inventories
20428000
Annuals > 1 > balance Sheet > total Current Assets
1275152000
Annuals > 1 > balance Sheet > property Plant Equipment
54239000
Annuals > 1 > balance Sheet > total Assets
1859245000
Annuals > 1 > balance Sheet > payables
100564000
Annuals > 1 > balance Sheet > short Term Debt
12537000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1524439000
Annuals > 1 > balance Sheet > equity
334806000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-466185000
Annuals > 1 > cash Flow > depreciation
16594000
Annuals > 1 > cash Flow > change In Working Capital
-79741000
Annuals > 1 > cash Flow > cash From Operations
-434655000
Annuals > 1 > cash Flow > capital Expenditures
12788000
Annuals > 1 > cash Flow > cash From Investing
-13745000
Annuals > 1 > cash Flow > cash From Financing
199650000
Annuals > 1 > cash Flow > net Change In Cash
-275361000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-8.685802665814876
Annuals > 1 > ratios > PB
0.044886230593239075
Annuals > 1 > ratios > ROE
-139.24033619469185
Annuals > 1 > ratios > ROA
-25.073887518858463
Annuals > 1 > ratios > FCF
-447443000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.37074111267988413
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
802879000
Annuals > 2 > income Statement > cost Of Revenue
15201000
Annuals > 2 > income Statement > gross Profit
787678000
Annuals > 2 > income Statement > operating Expenses
1224821000
Annuals > 2 > income Statement > operating Income
-421942000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-409417000
Annuals > 2 > income Statement > net Income
-412268000
Annuals > 2 > income Statement > eps
-7.77533332516071
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
53022550
Annuals > 2 > income Statement > income Tax Expense
273253
Annuals > 2 > income Statement > EBITDA
-412703000
Annuals > 2 > income Statement > operating Margin
-52.55362265048657
Annuals > 2 > income Statement > total Other Income Expense Net
12526000
Annuals > 2 > income Statement > currency_symbol
SEK
Annuals > 2 > balance Sheet > cash
119719098
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
7543269
Annuals > 2 > balance Sheet > inventories
349545
Annuals > 2 > balance Sheet > total Current Assets
135352334
Annuals > 2 > balance Sheet > property Plant Equipment
3059364
Annuals > 2 > balance Sheet > total Assets
187182202
Annuals > 2 > balance Sheet > payables
160404000
Annuals > 2 > balance Sheet > short Term Debt
10374000
Annuals > 2 > balance Sheet > long Term Debt
713030000
Annuals > 2 > balance Sheet > total Liabilities
113739823
Annuals > 2 > balance Sheet > equity
766264000
Annuals > 2 > balance Sheet > currency_symbol
SEK
Annuals > 2 > cash Flow > net Income
-39513722
Annuals > 2 > cash Flow > depreciation
1237643
Annuals > 2 > cash Flow > change In Working Capital
-9070362
Annuals > 2 > cash Flow > cash From Operations
-311354000
Annuals > 2 > cash Flow > capital Expenditures
240762
Annuals > 2 > cash Flow > cash From Investing
-5144000
Annuals > 2 > cash Flow > cash From Financing
575990000
Annuals > 2 > cash Flow > net Change In Cash
14089894
Annuals > 2 > cash Flow > currency_symbol
SEK
Annuals > 2 > ratios > PE
-7.77533332516071
Annuals > 2 > ratios > PB
0.019374933443304137
Annuals > 2 > ratios > ROE
-53.80234488374763
Annuals > 2 > ratios > ROA
-220.24957265969124
Annuals > 2 > ratios > FCF
-311594762
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.3880967891799387
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
229347000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
25353808
Annuals > 3 > income Statement > operating Expenses
753802000
Annuals > 3 > income Statement > operating Income
-524455000
Annuals > 3 > income Statement > interest Expense
7108000
Annuals > 3 > income Statement > pretax Income
-513373000
Annuals > 3 > income Statement > net Income
-500293000
Annuals > 3 > income Statement > eps
-9.842619176692635
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
50829255
Annuals > 3 > income Statement > income Tax Expense
-3836000
Annuals > 3 > income Statement > EBITDA
-494119000
Annuals > 3 > income Statement > operating Margin
-228.67314593171048
Annuals > 3 > income Statement > total Other Income Expense Net
14149000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
105629204
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1
Annuals > 3 > balance Sheet > inventories
98277
Annuals > 3 > balance Sheet > total Current Assets
111959725
Annuals > 3 > balance Sheet > property Plant Equipment
4378688
Annuals > 3 > balance Sheet > total Assets
161389851
Annuals > 3 > balance Sheet > payables
67971000
Annuals > 3 > balance Sheet > short Term Debt
9591000
Annuals > 3 > balance Sheet > long Term Debt
189164000
Annuals > 3 > balance Sheet > total Liabilities
49926596
Annuals > 3 > balance Sheet > equity
1008281000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-55306294
Annuals > 3 > cash Flow > depreciation
713917
Annuals > 3 > cash Flow > change In Working Capital
-1399644
Annuals > 3 > cash Flow > cash From Operations
-461588000
Annuals > 3 > cash Flow > capital Expenditures
728288
Annuals > 3 > cash Flow > cash From Investing
-24340000
Annuals > 3 > cash Flow > cash From Financing
435162000
Annuals > 3 > cash Flow > net Change In Cash
-40797000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-9.842619176692635
Annuals > 3 > ratios > PB
0.014115302579340483
Annuals > 3 > ratios > ROE
-49.618409947227015
Annuals > 3 > ratios > ROA
-309.9903723190128
Annuals > 3 > ratios > FCF
-462316288
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.015793919257719
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.00552185969495626
Valuation > metrics > PB
4.108143144817812
Valuation > final Score
38.91856855182188
Valuation > verdict
36.9% Overvalued
Profitability > metrics > ROE
-4.14179113611107
Profitability > metrics > ROA
-23.50409170702232
Profitability > metrics > Net Margin
-2736.304831210835
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.0016020698399643605
Risk > metrics > Interest Coverage
-509.5401269420973
Risk > final Score
-1978
Risk > verdict
High
Liquidity > metrics > Current Ratio
125.69205587079878
Liquidity > metrics > Quick Ratio
125.69205587079878
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
53.8355275021853
Prev Valuations > 1
20
Prev Valuations > 2
70
Prev Profitabilities > 0
46
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-1626
Prev Risks > 1
-20335
Prev Risks > 2
-5
Prev Liquidities > 0
20
Prev Liquidities > 1
10
Prev Liquidities > 2
100
Updated At
2026-01-20T21:37:06.527Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-08-31
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0055
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-03-31
Earnings History > 1 > report Date
2023-03-31
Earnings History > 1 > date
2023-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
SEK
Earnings History > 1 > eps Actual
-0.3347
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-02-22
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
SEK
Earnings History > 2 > eps Actual
-0.07
Earnings History > 2 > eps Estimate
-1.71
Earnings History > 2 > eps Difference
1.64
Earnings History > 2 > surprise Percent
95.9064
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-11-13
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
SEK
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-3.02
Earnings History > 3 > eps Difference
2.85
Earnings History > 3 > surprise Percent
94.3709
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-08-17
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
SEK
Earnings History > 4 > eps Actual
-3.62
Earnings History > 4 > eps Estimate
-4.23
Earnings History > 4 > eps Difference
0.61
Earnings History > 4 > surprise Percent
14.4208
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-05-17
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
SEK
Earnings History > 5 > eps Actual
-3.95
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-12-31
Earnings History > 6 > report Date
2022-02-23
Earnings History > 6 > date
2021-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
SEK
Earnings History > 6 > eps Actual
-4.19
Earnings History > 6 > eps Estimate
-3.72
Earnings History > 6 > eps Difference
-0.47
Earnings History > 6 > surprise Percent
-12.6344
Earnings History > 7 > period
2021-09-30
Earnings History > 7 > report Date
2021-11-17
Earnings History > 7 > date
2021-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
SEK
Earnings History > 7 > eps Actual
0.21
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2021-06-30
Earnings History > 8 > report Date
2021-08-18
Earnings History > 8 > date
2021-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
SEK
Earnings History > 8 > eps Actual
-3.2
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-03-31
Earnings History > 9 > report Date
2021-05-17
Earnings History > 9 > date
2021-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
SEK
Earnings History > 9 > eps Actual
-2.51
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-12-31
Earnings History > 10 > report Date
2021-02-17
Earnings History > 10 > date
2020-12-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
SEK
Earnings History > 10 > eps Actual
-0.2876
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-09-30
Earnings History > 11 > report Date
2020-11-11
Earnings History > 11 > date
2020-09-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
SEK
Earnings History > 11 > eps Actual
-0.4148
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-06-30
Earnings History > 12 > report Date
2020-08-12
Earnings History > 12 > date
2020-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
SEK
Earnings History > 12 > eps Actual
-0.3097
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.3097
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-03-31
Earnings History > 13 > report Date
2020-05-13
Earnings History > 13 > date
2020-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
SEK
Earnings History > 13 > eps Actual
-0.1608
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.1608
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-12-31
Earnings History > 14 > report Date
2020-02-13
Earnings History > 14 > date
2019-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
SEK
Earnings History > 14 > eps Actual
-0.1664
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.1664
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-09-30
Earnings History > 15 > report Date
2019-11-13
Earnings History > 15 > date
2019-09-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
SEK
Earnings History > 15 > eps Actual
-0.0636
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0636
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-06-30
Earnings History > 16 > report Date
2019-08-14
Earnings History > 16 > date
2019-06-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
SEK
Earnings History > 16 > eps Actual
-0.132
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.132
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-03-31
Earnings History > 17 > report Date
2019-05-07
Earnings History > 17 > date
2019-03-31
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
SEK
Earnings History > 17 > eps Actual
0.2531
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.2531
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2018-12-31
Earnings History > 18 > report Date
2019-02-06
Earnings History > 18 > date
2018-12-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
SEK
Earnings History > 18 > eps Actual
-0.13
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.13
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-09-30
Earnings History > 19 > report Date
2018-10-31
Earnings History > 19 > date
2018-09-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
SEK
Earnings History > 19 > eps Actual
-0.1417
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.1417
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-06-30
Earnings History > 20 > report Date
2018-08-16
Earnings History > 20 > date
2018-06-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
SEK
Earnings History > 20 > eps Actual
-0.1022
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.1022
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2018-03-31
Earnings History > 21 > report Date
2018-04-24
Earnings History > 21 > date
2018-03-31
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
SEK
Earnings History > 21 > eps Actual
-0.1206
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.1206
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2017-12-31
Earnings History > 22 > report Date
2018-03-31
Earnings History > 22 > date
2017-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
SEK
Earnings History > 22 > eps Actual
-0.2748
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.2748
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-09-30
Earnings History > 23 > report Date
2017-12-31
Earnings History > 23 > date
2017-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
SEK
Earnings History > 23 > eps Actual
-0.2987
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.2987
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-06-30
Earnings History > 24 > report Date
2017-09-30
Earnings History > 24 > date
2017-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
SEK
Earnings History > 24 > eps Actual
-0.1484
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.1484
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2017-03-31
Earnings History > 25 > report Date
2017-06-30
Earnings History > 25 > date
2017-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
SEK
Earnings History > 25 > eps Actual
-0.1301
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.1301
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2016-12-31
Earnings History > 26 > report Date
2017-03-31
Earnings History > 26 > date
2016-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
SEK
Earnings History > 26 > eps Actual
-0.099
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.099
Earnings History > 26 > surprise Percent
-
Calliditas Therapeutics AB (publ), a commercial-stage specialty pharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was founded in 2004 and is headquartered in Stockholm, Sweden.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAsahi Kasei To Pay A Fair Price For Calliditas Therapeutics (NASDAQ:CALT) Seeking Alpha
Read more →Calliditas Therapeutics: Undervalued Rare Disease Commercial Stage Biotech (Maintaining Buy) Seeking Alpha
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Calliditas Therapeutics AB (publ)
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.0055
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.